Gastroenterology

Gastroenterology

Volume 132, Issue 3, March 2007, Pages 982-993
Gastroenterology

Basic–alimentary tract
Sex Steroid Regulation of Macrophage Migration Inhibitory Factor in Normal and Inflamed Colon in the Female Rat

https://doi.org/10.1053/j.gastro.2006.12.028Get rights and content

Background & Aims: Sex steroids influence IBD symptoms. Macrophage migration inhibitory factor (MIF), a target of sex steroids in other inflammatory models, promotes interleukin (IL)-1β and tumor necrosis factor (TNF)-α release in colitis. We investigated whether estradiol and progesterone influence MIF, IL-1β, and TNF-α production in experimental colitis. Methods: Colonic MIF, IL-1β, and TNF-α levels were measured in cyclic and ovariectomized rats, with or without estradiol benzoate (EB) or progesterone (P) replacement. MIF distribution was assessed by immunohistochemistry. Cytokines, myeloperoxidase activity, macroscopic damage, and plasma corticosterone were assessed 24 hours after intrarectal trinitrobenzene sulfonic acid (TNBS), with and without neutralizing anti-MIF antibody. Effects of EB and P on myeloperoxidase activity and MIF concentration were also assessed at 7 days in dextran sulfate sodium-induced colitis. Results: Basal IL-1β and TNF-α contents did not fluctuate during the estrous cycle, while MIF concentrations increased from estrus (estrogen dominance) to metestrus (P dominance; P < .05). EB and P treatment mimicked these effects in ovariectomized rats, and similarly altered MIF immunostaining. Progesterone dominance aggravated TNBS colitis in comparison with estrogen. Progesterone enhanced TNBS-induced MIF (P < .001) and TNF-α (P < .01) production, while EB decreased MIF (P < .01) and IL-β levels (P < .01). Anti-MIF antibody prevented P-mediated up-regulation of TNF-α, improved TNBS colitis, and enhanced plasma corticosterone. At 7 days after dextran sulfate sodium, EB decreased myeloperoxidase activity and MIF concentration, while P had no effect. Conclusions: Estrogen decreases while progesterone increases MIF production in the female rat colon. Changes in basal MIF contents may affect colon susceptibility to inflammation, by modulating TNF-α and IL-1β production during early stages of colitis.

Section snippets

Animals

Adult female Wistar rats (Charles River, Saint-Aubin-Lès-Elbeuf, France) were housed in groups of 4 with free access to food and water, under a 12 hour:12 hour light:dark cycle. All protocols were approved by the local institutional Animal Care and Use Committee, in compliance with the European laws on the protection of animals (86/609/EEC).

Determination of Estrous Cycle Stages and Ovariectomy

In a first experiment, estrous cycle stages were assessed through daily vaginal smears, as previously described.30 Only rats displaying regular cycles were

MIF, IL-1β, and TNF-α Colonic Contents During the Estrous Cycle, and Effect of Ovariectomy

MIF concentrations increased significantly from the follicular to the luteal phase of the cycle (Figure 1A) (301 ± 39 and 781 ± 135 ng/mg of protein in estrus and metestrus, respectively; P < .05). In the same rats, no significant variation was observed throughout the cycle for IL-1β (range, 28 ± 3 to 38 ± 5 pg/mg of protein) and TNF-α (range, 3.6 ± 0.1 to 4.1 ± 0.3 pg/mg of protein) (Figure 1B and C).

In OVX rats, MIF concentrations were decreased (117 ± 28 vs. 628 ± 85 ng/mg of protein in the

Discussion

The current study shows that female sex hormones are involved in the control of MIF expression in the normal and inflamed colon. In IBD and animal models of colitis, MIF is a proinflammatory cytokine that stimulates the production of TNF-α and IL-1β,20, 21 both playing a central role in the initiation and perpetuation of mucosal inflammation.37, 38, 39 Our study in female rats provides evidence of a relationship between basal MIF levels, estrous cycle-dependent hormonal status, and the capacity

References (61)

  • L. Mazelin et al.

    Vagally dependent protective action of calcitonin gene-related peptide on colitis

    Peptides

    (1999)
  • G. Improta et al.

    Central effects of selective NK1 and NK3 tachykinin receptor agonists on two models of experimentally-induced colitis in rats

    Peptides

    (2003)
  • C. Rojas-Cartagena et al.

    Role of tumor necrosis factor receptors in an animal model of acute colitis

    Cytokine

    (2005)
  • A.M. Aloisi et al.

    Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF)

    Pain

    (2005)
  • M. Chalimoniuk et al.

    Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons

    Neuroscience

    (2006)
  • P.A. Konstantinopoulos et al.

    Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiation

    Eur J Cancer

    (2003)
  • J.M. Wilson et al.

    Macrophage migration inhibitory factor promotes intestinal tumorigenesis

    Gastroenterology

    (2005)
  • K. Nanda et al.

    Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis

    Obstet Gynecol

    (1999)
  • Y. Arai et al.

    Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice

    Cytokine

    (1998)
  • S. Schreiber et al.

    Tumor necrosis factor α and interleukin 1β in relapse of Crohn’s disease

    Lancet

    (1999)
  • S. Nikolaus et al.

    Mechanisms in failure of infliximab for Crohn’s disease

    Lancet

    (2000)
  • P. Rutgeerts et al.

    Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease

    Gastroenterology

    (1999)
  • X.R. Huang et al.

    Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats

    Gastroenterology

    (2001)
  • R. Maunder et al.

    Influence of sex and disease on illness-related concerns in inflammatory bowel disease

    Can J Gastroenterol

    (1999)
  • T. Bernklev et al.

    Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis

    Scand J Gastroenterol

    (2004)
  • C.N. Bernstein et al.

    The epidemiology of inflammatory bowel disease in Canada: a population-based study

    Am J Gastroenterol

    (2006)
  • A.K. Gurbuz et al.

    Premarin-induced ischemic colitis

    J Clin Gastroenterol

    (1994)
  • L.A. Garcia Rodriguez et al.

    Risk factors for inflammatory bowel disease in the general population

    Aliment Pharmacol Ther

    (2005)
  • O. Gunal et al.

    Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats

    Inflammation

    (2003)
  • D.C. Harnish et al.

    Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease

    Am J Physiol Gastrointest Liver Physiol

    (2004)
  • Cited by (73)

    • Dysregulation of cytokine coding genes in peripheral blood of bipolar patients

      2019, Journal of Affective Disorders
      Citation Excerpt :

      Benedek et al. have shown higher levels of this cytokine in males with progressive MS compared with female MS patients and suggested MIF as a sex-specific disease modifier (Benedek et al., 2017). This cytokine has both pro- and anti-depressant functions (Bloom and Al-Abed, 2014) and is recognized to have sex-specific functions in inflammation, wound healing and response to ischemic stroke (Houdeau et al., 2007; Turtzo et al., 2013). Notably, we demonstrated higher expression of CXCL8 in total patients, male patients and female patients compared with the corresponding control groups.

    • Bisphenol A—Induced changes in the enteric nervous system of the porcine duodenum

      2018, NeuroToxicology
      Citation Excerpt :

      It is known that this substance may alter the intestinal barrier function and gut nociception. Moreover, acting on the estrogen receptors, which are widely expressed in epithelial and immune cells of the digestive tract (Campbell-Thompson et al., 2001; Konstantinopoulos et al., 2003), BPA may be involved in processes associated with gastrointestinal inflammation (Harnish et al., 2004; Houdeau et al., 2007; Verdú et al., 2002). Some studies also suggest that perinatal or juvenile period exposure to xenoestrogens (including BPA) is a factor predisposing to inflammatory bowel disease, Crohn’s disease or ulcerative colitis in later life (for review, see Braniste et al., 2011).

    • Role of sex and aging in mucosal health

      2018, Conn's Handbook of Models for Human Aging
    View all citing articles on Scopus

    Supported by the Institut National de la Recherche Agronomique (INRA).

    View full text